Multi-step high-throughput conjugation platform for the development of antibody-drug conjugates

•Complete multi-step protein conjugation process on liquid handling station.•Reagent removal by automated intermediate buffer exchange step.•Automated intermediate protein quantification with process feedback.•Case studies demonstrating efficiency and comparability. Antibody-drug conjugates (ADCs) f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of biotechnology 2018-07, Vol.278, p.48-55
Hauptverfasser: Andris, Sebastian, Wendeler, Michaela, Wang, Xiangyang, Hubbuch, Jürgen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Complete multi-step protein conjugation process on liquid handling station.•Reagent removal by automated intermediate buffer exchange step.•Automated intermediate protein quantification with process feedback.•Case studies demonstrating efficiency and comparability. Antibody-drug conjugates (ADCs) form a rapidly growing class of biopharmaceuticals which attracts a lot of attention throughout the industry due to its high potential for cancer therapy. They combine the specificity of a monoclonal antibody (mAb) and the cell-killing capacity of highly cytotoxic small molecule drugs. Site-specific conjugation approaches involve a multi-step process for covalent linkage of antibody and drug via a linker. Despite the range of parameters that have to be investigated, high-throughput methods are scarcely used so far in ADC development. In this work an automated high-throughput platform for a site-specific multi-step conjugation process on a liquid-handling station is presented by use of a model conjugation system. A high-throughput solid-phase buffer exchange was successfully incorporated for reagent removal by utilization of a batch cation exchange step. To ensure accurate screening of conjugation parameters, an intermediate UV/Vis-based concentration determination was established including feedback to the process. For conjugate characterization, a high-throughput compatible reversed-phase chromatography method with a runtime of 7 min and no sample preparation was developed. Two case studies illustrate the efficient use for mapping the operating space of a conjugation process. Due to the degree of automation and parallelization, the platform is capable of significantly reducing process development efforts and material demands and shorten development timelines for antibody-drug conjugates.
ISSN:0168-1656
1873-4863
DOI:10.1016/j.jbiotec.2018.05.004